LINC03011: A Drug Target / Disease Biomarker (G100289098)

Target Name: LINC03011

NCBI ID: G100289098

LINC03011

Other Name(s): long intergenic non-protein coding RNA 3011 | GS1-124K5.4 | Long intergenic non-protein coding RNA 3011, transcript variant 3

LINC03011: A Drug Target / Disease Biomarker

LINC03011 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of cell adhesion and has been shown to play a role in a variety of biological processes, including cancer progression and neurodegeneration.

LINC03011 is a long non-coding RNA molecule that contains more than 200 amino acid residues. It is expressed in a variety of tissues and cells and has been shown to play a role in cell adhesion, cell signaling, and chromatin regulation.

One of the most promising aspects of LINC03011 is its potential as a drug target. LINC03011 has been shown to interact with a variety of protein molecules, including the transcription factor NF-kappa-B. This suggests that LINC03011 may be a good candidate for drugs that target the NF-kappa-B pathway.

In addition to its potential as a drug target, LINC03011 has also been shown to be a valuable biomarker for a variety of diseases. For example, LINC03011 has been shown to be downregulated in a variety of cancer types, including breast, ovarian, and prostate cancers. This suggests that LINC03011 may be a useful biomarker for these cancers.

Another potential application of LINC03011 is its role in neurodegeneration. LINC03011 has been shown to be involved in the regulation of synaptic plasticity, which is the ability of the brain to change and adapt over time. This suggests that LINC03011 may be a good candidate for drugs that target neurodegeneration.

In conclusion, LINC03011 is a non-coding RNA molecule that has a variety of potential applications as a drug target and biomarker. Its ability to interact with transcription factors and its potential as a regulator of cell adhesion and neuroplasticity make it an attractive candidate for further research. Further studies are needed to fully understand the role of LINC03011 in these processes and to determine its potential as a drug and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 3011

The "LINC03011 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC03011 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets